# GE HealthCare Technologies Inc.: filings

GEHC · Nasdaq · CIK 1932393 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gehc.md) · [Financials](/companies/gehc/financials.md) · [Filings](/companies/gehc/filings.md) · [Insiders](/companies/gehc/insiders.md)

## Reports and events: 78 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 217, 8-K 54, 3 29, 144 14, 424B3 12, 10-Q 11, CORRESP 9, SCHEDULE 13G/A 9, 424B2 6, FWP 6, UPLOAD 6, 10-K 4, ARS 4, DEF 14A 4, DEFA14A 4, EFFECT 4, SD 4, 10-12B/A 3, S-3ASR 3, SC 13G 3, SC 13G/A 3, SCHEDULE 13G 3, 424B4 2, 8-K/A 2, DRS 2, S-1 2, S-8 2, 10-12B 1, 4/A 1, CERT 1, DRS/A 1, DRSLTR 1, POS AM 1, S-1/A 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 06:25 ET | [8-K](/filings/0001932393-26-000058.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001932393-26-000058 |
| 2026-09-22 | 16:07 ET | [8-K](/filings/0001932393-26-000053.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-26-000053 |
| 2026-08-18 | 09:03 ET | [8-K](/filings/0001932393-26-000050.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001932393-26-000050 |
| 2026-07-29 | 06:27 ET | [8-K](/filings/0001932393-26-000047.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-26-000047 |
| 2026-07-29 | 06:27 ET | [10-Q](/filings/0001932393-26-000046.md) | Quarterly report, period 2026-06-30 | 0001932393-26-000046 |
| 2026-07-29 | 06:25 ET | [8-K](/filings/0001932393-26-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-26-000045 |
| 2026-07-23 | 16:17 ET | [8-K](/filings/0001932393-26-000039.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001932393-26-000039 |
| 2026-05-11 | 16:51 ET | [8-K](/filings/0001932393-26-000034.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001932393-26-000034 |
| 2026-04-29 | 06:26 ET | [10-Q](/filings/0001932393-26-000031.md) | Quarterly report, period 2026-03-31 | 0001932393-26-000031 |
| 2026-04-29 | 06:25 ET | [8-K](/filings/0001932393-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-26-000030 |
| 2026-03-19 | 07:02 ET | [DEF 14A](/filings/0001932393-26-000021.md) | Proxy statement, period 2026-05-07 | 0001932393-26-000021 |
| 2026-03-17 | 09:14 ET | [8-K](/filings/0001932393-26-000013.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-26-000013 |
| 2026-02-27 | 16:15 ET | [8-K](/filings/0001932393-26-000010.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001932393-26-000010 |
| 2026-02-04 | 06:28 ET | [10-K](/filings/0001932393-26-000007.md) | Annual report, period 2025-12-31 | 0001932393-26-000007 |
| 2026-02-04 | 06:25 ET | [8-K](/filings/0001932393-26-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-26-000006 |
| 2025-12-15 | 17:02 ET | [8-K](/filings/0001193125-25-319383.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-319383 |
| 2025-12-02 | 16:55 ET | [8-K](/filings/0001193125-25-305400.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-305400 |
| 2025-10-29 | 06:26 ET | [10-Q](/filings/0001932393-25-000053.md) | Quarterly report, period 2025-09-30 | 0001932393-25-000053 |
| 2025-10-29 | 06:25 ET | [8-K](/filings/0001932393-25-000052.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-25-000052 |
| 2025-07-30 | 06:27 ET | [10-Q](/filings/0001932393-25-000049.md) | Quarterly report, period 2025-06-30 | 0001932393-25-000049 |
| 2025-07-30 | 06:25 ET | [8-K](/filings/0001932393-25-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-25-000048 |
| 2025-07-24 | 16:33 ET | [8-K](/filings/0001932393-25-000044.md) | 5.02 Departure or appointment of officers or directors | 0001932393-25-000044 |
| 2025-06-09 | 16:07 ET | [8-K](/filings/0001932393-25-000041.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001932393-25-000041 |
| 2025-06-04 | 16:50 ET | [8-K](/filings/0001932393-25-000039.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001932393-25-000039 |
| 2025-05-30 | 08:59 ET | [8-K](/filings/0001932393-25-000032.md) | 5.07 Shareholder vote results | 0001932393-25-000032 |
| 2025-04-30 | 06:26 ET | [10-Q](/filings/0001932393-25-000014.md) | Quarterly report, period 2025-03-31 | 0001932393-25-000014 |
| 2025-04-30 | 06:25 ET | [8-K](/filings/0001932393-25-000013.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001932393-25-000013 |
| 2025-04-10 | 07:07 ET | [DEF 14A](/filings/0001628280-25-017240.md) | Proxy statement, period 2025-05-28 | 0001628280-25-017240 |
| 2025-03-31 | 17:09 ET | [8-K](/filings/0001932393-25-000007.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001932393-25-000007 |
| 2025-02-13 | 06:26 ET | [10-K](/filings/0001932393-25-000005.md) | Annual report, period 2024-12-31 | 0001932393-25-000005 |
| 2025-02-13 | 06:25 ET | [8-K](/filings/0001932393-25-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-25-000004 |
| 2024-12-12 | 16:30 ET | [8-K](/filings/0001193125-24-277089.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-277089 |
| 2024-11-21 | 06:05 ET | [8-K](/filings/0001932393-24-000054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-24-000054 |
| 2024-11-08 | 16:59 ET | [8-K](/filings/0001193125-24-254226.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-254226 |
| 2024-10-30 | 06:33 ET | [8-K](/filings/0001932393-24-000051.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001932393-24-000051 |
| 2024-10-30 | 06:32 ET | [10-Q](/filings/0001932393-24-000050.md) | Quarterly report, period 2024-09-30 | 0001932393-24-000050 |
| 2024-10-30 | 06:31 ET | [8-K](/filings/0001932393-24-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000049 |
| 2024-09-13 | 17:24 ET | [8-K](/filings/0001193125-24-218963.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-218963 |
| 2024-08-15 | 16:37 ET | [8-K](/filings/0001193125-24-201356.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-201356 |
| 2024-08-09 | 16:54 ET | [8-K](/filings/0001193125-24-197921.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-197921 |
| 2024-07-31 | 06:26 ET | [10-Q](/filings/0001932393-24-000044.md) | Quarterly report, period 2024-06-30 | 0001932393-24-000044 |
| 2024-07-31 | 06:25 ET | [8-K](/filings/0001932393-24-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000043 |
| 2024-05-23 | 16:05 ET | [8-K](/filings/0001628280-24-024926.md) | 5.07 Shareholder vote results | 0001628280-24-024926 |
| 2024-04-30 | 06:27 ET | [10-Q](/filings/0001932393-24-000034.md) | Quarterly report, period 2024-03-31 | 0001932393-24-000034 |
| 2024-04-30 | 06:25 ET | [8-K](/filings/0001932393-24-000033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000033 |
| 2024-04-15 | 17:00 ET | [8-K](/filings/0001932393-24-000027.md) | 5.02 Departure or appointment of officers or directors | 0001932393-24-000027 |
| 2024-04-04 | 07:06 ET | [DEF 14A](/filings/0001932393-24-000022.md) | Proxy statement, period 2024-05-21 | 0001932393-24-000022 |
| 2024-03-14 | 17:16 ET | [8-K](/filings/0001193125-24-068035.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-068035 |
| 2024-02-16 | 17:10 ET | [8-K](/filings/0001193125-24-038569.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-038569 |
| 2024-02-06 | 12:08 ET | [8-K/A](/filings/0001932393-24-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001932393-24-000017 |

Page 1 of 2. [Older](/companies/gehc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 06:27 ET. No prices; not investment advice.